AQR Capital Management »

Tarsus Pharmaceuticals shares owned by AQR Capital Management

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $655k 20k 32.89
2024-06-30 $204k 7.5k 27.18
2024-03-31 $371k 10k 36.35

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Tarsus Pharmaceuticals

BlackRock
BlackRock
Paradigm Biocapital Advisors
Tang Capital Management
Cowen And Company
Jennison Associates
Vanguard Group
Morgan Stanley
Frazier Life Sciences Management
Perceptive Advisors
Assenagon Asset Management
Ikarian Capital
State Street Corporation
ExodusPoint Capital Management
Geode Capital Management

View all funds holding Tarsus Pharmaceuticals